Literature DB >> 15006823

Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials.

Rogerio A Lobo1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15006823     DOI： 10.1001/archinte.164.5.482

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

Review 2.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

3.  A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  C Noel Bairey Merz; Marian B Olson; Candace McClure; Yu-Ching Yang; James Symons; George Sopko; Sheryl F Kelsey; Eileen Handberg; B Delia Johnson; Rhonda M Cooper-DeHoff; Barry Sharaf; William J Rogers; Carl J Pepine
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

4.  Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Authors:  Sengwee Toh; Sonia Hernández-Díaz; Roger Logan; Jacques E Rossouw; Miguel A Hernán
Journal:  Ann Intern Med       Date:  2010-02-16       Impact factor: 25.391

Review 5.  Should symptomatic menopausal women be offered hormone therapy?

Authors:  Rogerio A Lobo; Serge Bélisle; William T Creasman; Nancy R Frankel; Neil F Goodman; Janet E Hall; Susan Lee Ivey; Sheryl Kingsberg; Robert Langer; Rebecca Lehman; Donna Behler McArthur; Valerie Montgomery-Rice; Morris Notelovitz; Gary S Packin; Robert W Rebar; MaryEllen Rousseau; Robert S Schenken; Diane L Schneider; Katherine Sherif; Susan Wysocki
Journal:  MedGenMed       Date:  2006

Review 6.  Postmenopausal hormone therapy: lessons from observational and randomized studies.

Authors:  Giuseppe M C Rosano; Cristiana Vitale; Stefano Lello
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.925

7.  Is the WHI relevant to HRT started in the perimenopause?

Authors:  S Mitchell Harman; Eliot A Brinton; Thomas Clarkson; Christopher B Heward; Harvey S Hecht; Richard H Karas; Debra R Judelson; Frederick Naftolin
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.925
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.